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Teichoic acids (ТA) belong to the main structural 
components of bacterial cells. By the type of polyol 
in their content, there are ribitteichoic and glycerol-
teichoic acids, and by localization — cell wall TA and 
membrane TA [1, 2]. Membrane TA is linked by cova-
lent bond with glycolipid of cytoplasmic membrane and 
are named lypoteichoic acids (LTA) [3, 4]. The ability 
of LTA to initiate proinflammatory immune response is 
in large part mediated by lipid component and allows 
consider them as potential therapeutic agents for the 
treatment of cancer [5–7]. Immunoenhancing and 
biological properties of cell wall TA are poorly studied 
yet; it is known that upon microbial infection and upon 
administration to animals, cell wall TA and their deriva-
tives  cause biological effects [8, 9]. By activation of the 
synthesis of inducible NO-synthase in different organs 
(liver, kidney etc), they lead to significant elevation of 
the level of nitrites in blood plasma and to the deve-
lopment of the multiple organ disfunction syndrome 
[10, 11]. Together with other bacterial components, 
cell wall TA is able to cause direct toxic on euka ryotic 
cells [12]. It is necessary to note that structural poly-
morphism of the TA preparations determines the dif-
ferences in their biological effects [13, 14].
The recognition of TA and LTA by effector cells of 
immune system occurs with the involvement of Toll-
like receptors, in particular TLR4 and TLR2 [15, 16]. 
Toll-like receptors play an important role in the induc-
tion of antitumor immune reactions. Agonists of these 
receptors are used as adjuvants in antitumor therapy 
[17–19]. TLR activation on the surface of antigen pre-
senting cells such as dendritic cells and macrophages 
leads to activation of their functional maturation which 
manifests itself in elevation of MHC molecules expres-
sion, activation of synthesis and secretion of proin-
flammatory cytokines required for maturation of Th1 
lymphocytes and cytotoxic T-lymphocytes [20, 21]. 
It is known also that activation of TLRs on the surface 
of tumor-induced suppressor CD4+Тreg cells leads to 
abrogation of their suppressor functions.
The aim of present work was to study the influ-
ence of cell wall TA from S. aureus on the indices of 
immunologic reactivity of mice bearing Lewis lung 
carcinoma (LLC).
Materials and Methods 
Isolation of teichoic acid. Teichoic acid was 
isolated from the cell walls of Staphylococcus aureus 
Wood 46. The strain was obtained from the Bacterial 
Culture Museum of the Cathedra of Microbiology and 
General Immunolo gy of T.G. Shevchenko Kyiv National 
University (Kyiv, Ukraine). The preparation was isolated 
as described earlier [20] by the method of Archibald.
Experimental animals and experimental tumor 
model. In the experiments, female С57/Bl6 mice 
2–3 months old weighting 20–25 g bred in the vivarium 
of biological faculty of T.G. Shevchenko Kyiv National 
University (Kyiv, Ukraine) were used. All animal proce-
dures were carried out according to the rules of local 
Ethic Committee.
The strain of metastatic Lewis lung carcinoma was 
kindly supplied by the Bank of Cell Cultures and Trans-
plantable Experimental Tumor of 3LL of R.E. Kavetsky 
Institute of Experimental Pathology, Oncology and Ra-
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diobiology (Kyiv, Ukraine). LLC cells were transplanted 
subcutaneously in sacral region by 0.2 ml of 20% cell 
suspension.
TA at the doses of 0.5, 1, or 2 µg/g of body weight at 
the volume of 0.2 ml was administered subcutaneously 
in the sacral region simultaneously with LLC transplan-
tation. Introduction of TA was repeatedly given in a 
7 days. Thus, total doses were 1, 2, or 4 µg/g of body 
weight respectively. Results haven been registered on 
the 35th day after the tumor cells transplantation.
Animals were housed in 5 groups (n = 10 per 
group) as follow: 1) intact animals (group A); 2) con-
trol LLC-bearing mice (group B); 3) LLC-bearing ani-
mals that received TA at a dose of 1 µg/g (group C); 
4) LLC-bearing animals that received TA at a dose of 
2 µg/g (group D); 5) LLC-bearing animals that received 
TA at a dose of 4 µg/g(group E).
Metabolic activity of peritoneal macrophages 
was determined by reduction of nitroblue tetrazolium 
(NBT) by [21].  For stimulation of oxygen-dependent 
metabolism PMA solution (Sigma) was used.
Cytotoxic activity of splenocytes was deter-
mined by the method of flow cytometry [22]. LLC 
cells served as the target cells. Effector cells and 
target cells were mixed at the ratio of 25 : 1 in RPMI-
1640 medium (Sigma) supplemented with 10% fetal 
calf serum, 2 mМ L-glutamine (Sigma) and 40 µg/ml 
gentamycine for 6 h at 37 °С in СО2 incubator. Then 
cell mixture was placed in cytometric tubes (Falcon) 
and mixed with 2,5 µg/ml propidium iodide (Sigma). 
The samples were analyzed on flow cytometer Facs-
Calibur (Becton Dickinson) using CellQuest program. 
The percent of lyzed target cells was calculated by a 
formula: X = E – С, where E — % of lyzed target cells 
in experimental sample, and C — % of spontaneous 
lysis of target cells.
Isolation of mononuclear cells infiltrating tu-
mor. Tumor tissues were mechanically disintegrated 
by scissors, homogenized in Potter’s homogenizer, 
and treated by trypsin solution (1 : 250) in citrate buffer, 
рН 7.8, containing 150 мл NaCl [23]. Cell suspension 
was triply washed with cold Henks solution. Mono-
nuclear cells were isolated from cell suspension by 
centrifugation in ficoll-verografin gradient (ρ = 1.077). 
For standartization of the results, the data were pre-
sented as specific cell content (C1) calculated by the 
formula:
Cl = (total number of mononuclear cells / tumor 
weight) х 105.
Statistical analysis of obtained data was per-
formed with the use of Students t-test. 
results and discussion
Administration of TA to LLC-bearing mice resulted 
in different influence on tumor growth dependently 
of the TA dose (Table). In animals that received TA at 
the doses of 1 µg/g and 2 µg/g, stimulation of tumor 
growth has been observed and the volume of primary 
tumors  2.5 fold higher than those in group B, while 
the number of metastases was by 65 and 28% higher, 
respectively. It is necessary to note that metastasis 
level in experimental animals was characterized by 
notable individual variability. In mice that received TA 
at a dose of 4 µg/g, at the moment of the experiment 
cessation the volumes of primary tumors were 4-fold 
lower compared to the control, and lung metastases 
were absent.
Table. Influence of teichoic acid of S. aureus on the growth parameters 
of LLC in mice
TA-treated animals, 
TA doses
Volume of primary 
tumor (cm3)
Number 
of metastases per 
animal (M ± m)
IMI, 
%*
4 µg/g, (n = 10) 0.230 ± 0.025** 0** 100
2 µg/g, (n = 10) 2.301 ± 0.098** 17.92 ± 6.04 –
1 µg/g, (n = 10) 2.461 ± 0.122** 23.15 ± 5.85 –
Untreated animals (n = 10) 0.941 ± 0.051 14.0 ± 6.15
Notes: *IMI (index of metastasis inhibition, %) was calculated by the formula 
IMI = [1 – E/C] x 100%, where C and E – average number of metastases 
per animal from control and experimental groups respectively; **P < 0.05 
compared with untreated tumor-bearing animals.
The influence of TA on tumor growth may be media-
ted by two ways: by direct toxic influence on tumor 
cells [12]; and via Toll-like-dependent activation of 
antitumor immunity. For evaluation of the impact of im-
mune system mediating TA influence on tumor growth, 
we have studied some indices of immunologic reac-
tivity of experimental animals that play an important 
role in antitumor immunity, namely metabolic activity 
of peritoneal macrophages and cytotoxic activity of 
splenocytes and the relative content of mononuclear 
cells in tumor tissue.
Mononuclear phagocytes are an important com-
ponent of antitumor resistance. Proinflammatory ac-
tivation of macrophages directed toward elimination 
of tumor cells as well, is accompanied by so-called 
“oxygen burst” [24, 25]. According to our data, spon-
taneous metabolic activity of macrophages in control 
LLC-bearing animals was similar to that of intact ani-
mals (Fig. 1), and administration of TA at the doses of 
1 µg/g, 2 µg/g did not cause statistically significant 
alteration of this index. TA at a dose of 4 µg/g caused 
insignificant decrease of oxygen-dependent metabo-
lism of macrophages.
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fig. 1. Influence of teichoic acid from S. aureus on spontaneous 
metabolic activity of peritoneal macrophages from LLC-bearing 
mice. A — intact animals, n = 10; B — untreated tumor-bearing 
animals, n = 10; C — tumor-bearing animals that received TA at a 
dose of 1 µg/g, n = 10; D — tumor-bearing animals that received 
TA at a dose of 2 µg/g, n = 10; E — tumor-bearing animals that 
received TA at a dose of 4 µg/g, n = 10
*P < 0.05 compared with intact animals; **P < 0.05 compared 
with untreated tumor-bearing animals.
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The level of stimulated metabolic activity of peri-
toneal macrophages that characterizes the state of 
their metabolic reserve was by 25% higher in group B 
than that in group A (Fig. 2). In TA-treated animals this 
index did not differ significantly from that in control 
LLC-bearing animals and was moderately higher than 
in group A. It’s necessary to note that in total TA has 
no prolonged (up to 30 days) influence on metabolic 
activity of peritoneal macrophages.
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fig. 2. Influence of teichoic acid from S. aureus on stimulated 
metabolic activity of peritoneal macrophages of LLC-bearing 
mice. A — intact animals, n = 10; B — untreated tumor-bearing 
animals, n = 10; C — tumor-bearing animals that received TA at a 
dose of 1 µg/g, n = 10; D — tumor-bearing animals that received 
TA at a dose of 2 µg/g, n = 10; E — tumor-bearing animals that 
received TA at a dose of 4 µg/g, n = 10 
*P < 0.05 compared with a intact animals; **P < 0.05 compared 
with untreated tumor-bearing animals.
Splenocytes may control an appearance and 
perform unspecific elimination of tumor cells [26]. It 
may be mentioned (Fig. 3) that in group B the level 
of cytotoxic activity of splenocytes was twice lower 
than in group A. Administration of TA caused a dose-
dependent stimulation of the activity of these cells, 
and upon administration of TA at a dose of 4 µg/g the 
level of this index reached the values characteristic 
for intact animals. 
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fig. 3. Influence of teichoic acid from S. aureus on the indices of 
cytotoxic activity of splenocytes of LLC-bearing mice. A — intact 
animals, n = 10; B — untreated tumor bearing animals, n = 10; 
C — tumor-bearing animals that received TA at a dose of 1 µg/g, 
n = 10; D — tumor-bearing animals that received TA at a dose of 
2 µg/g, n = 10; E — tumor-bearing animals that received TA at 
a dose of 4 µg/g, n = 10 
*P < 0.05 compared with intact animals; **P < 0.05 compared 
with untreated tumor-bearing animals.
During its growth, malignant tumor became infil-
trated by lymphoid cells that dependent on their sub-
populations could either suppress or promote tumor 
growth. According to our results, TA administration 
at all studied doses resulted in the suppression of 
tumor infiltration by mononuclear cells compared to 
group B (Fig. 4), but there was a reverse dependence 
between the dose and the degree of such suppres-
sion. Possibly, such phenomenon could be explained 
by a dose-dependent influence of TA on chemokine 
production [27, 28].
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fig. 4. Influence of teichoic acid from S. aureus on the content 
of mononuclear cells in tumor tissue of LLC-bearing mice. 
B — untreated tumor-bearing animals, n = 10; F — tumor-
bearing animals that received TA at a dose of 1 µg/g, n = 10; 
G — tumor-bearing animals that received TA at a dose of 2 µg/g, 
n = 10; H — tumor-bearing animals that received TA at a dose 
of 4 µg/g, n = 10 
k* — number of leucocytes per 1 mg of tumor tissue.
Inhibition of growth and metastasis of LLC upon 
the influence of TA may be due to a combined action 
of the preparation on tumor cells as well as on effec-
tor cells of immune system. Taking into account the 
ability of TA to stimulate iNOS production by normal 
and malignant transformed cells, one may propose 
the accumulation of significant amount of NO causing 
cell damage in the place of injection of the preparation 
(region of tumor cell transplantation). Because of cell 
destruction, the local inflammation manifesting itself 
in point ulceration of animal’s skin was observed. The 
development of local inflammation promoted inhibition 
of tumor growth and metastasis of LLC.
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влияние тейхоевой кислоты S. aurEuS 
на МетаБолиЧескУЮ активность Макрофагов 
и ЦитотоксиЧескУЮ активность сПленоЦитов Мышей 
с карЦиноМой легкого льЮис
Цель: исследовать влияние тейхоевой кислоты Staphylococcus aureus Wood 46 (ТК) на иммунологические параметры у мышей 
с карциномой легкого Льюис. Методы: в качестве модели использовали перевиваемую карциному легкого Льюис. Тейхоевую 
кислоту S. aureus Wood 46 получали по методу Арчибальда. Кислородзависимый метаболизм перитонеальных макрофагов 
оценивали по восстановлению нитросинего тетразолия (НСТ-тест). Цитотоксическую активность спленоцитов определяли 
методом проточной цитофлуориметрии. Результаты: ТК оказывала дозозависимое влияние на рост и метастазирование 
карциномы Льюис. У животных, получивших ТК в дозе 4 мкг/г, размеры первичной опухоли были на момент окончания 
эксперимента в 4 разa меньше по сравнению с контролем, метастазы в легких отсутствовали. ТК незначительно стимулиро-
вала кислородзависимый метаболизм перитонеальных макрофагов. Отмечали дозозависимую активацию цитотоксической 
активности спленоцитов: при использовании ТК в дозе 4 мкг/г цитотоксическая активность спленоцитов у животных опытной 
группы в 2 раза превышала показатели контрольных животных-носителей опухолей. Выводы: ТК оказывает дозозависимое 
ингибиторное влияние на рост и метастазирование карциномы легкого Льюис. Одним из механизмов, опосредующих супрес-
сорное действие ТК на опухолевый рост, можнo считать активацию цитотоксической активности спленоцитов. 
Ключевые слова: карцинома легкого Льюис, тейхоевая кислота, кислородзависимый метаболизм, перитониальные ма-
крофаги, спленоциты, цитотоксическая активность.
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